Skip to main content

Table 1 RNA yield and quality before and after DNase I treatment

From: I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice

Samples before Dnase I treatment

OD260

OD280

OD260/ OD280

RNA concentration(ng/μl)

IVBD-1

17.079

8.765

1.95

683.14

IVBD-2

15.494

7.962

1.95

619.77

IVBD-3

5.603

3.829

1.46

224.11

IVBD-4

11.815

5.889

2.01

472.58

IVBD-5

17.626

8.540

2.06

705.05

Control-1

13.908

7.215

1.93

556.32

Control-2

9.294

4.841

1.92

371.75

Control-3

11.153

5.965

1.87

446.14

Control-4

14.234

7.344

1.94

569.36

Control-5

14.797

7.684

1.93

591.89

Samples after DNase I treatment

OD 260

OD 280

OD 260 / OD 280

RNA concentration(ng/ul)

IVBD-1

7.994

3.939

2.03

319.76

IVBD-2

6.840

3.493

1.96

273.59

IVBD-3

5.417

2.769

1.96

216.68

IVBD-4

8.579

4.371

1.96

343.16

IVBD-5

12.352

6.073

2.03

494.08

Control-1

4.455

2.307

1.93

178.20

Control-2

4.807

2.405

2.00

192.27

Control-3

10.141

5.244

1.93

405.63

Control-4

10.424

5.408

1.93

416.96

  1. IVBD, ivabradine.